Pay in 4 interest-free payments of $7.08 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
MarketScan contains claims information provided by a sample of large employer plans, made representative of the ESI market by using weights to match counts in the Current Population Survey for enrollees at firms of 1,000 or more workers, adjusting by sex, age, and state
However, in the 5 years its been on the market, according to the Calocarb website, there have been no reports of other concerning side effects
The first few days after a dose increase are often when side effects are strongest
Because it's a relatively new compound, the public data is still emerging
Cost comparison Direct cost comparison is complicated by the fact that retatrutide has no commercial pricing yet
1 Flow chart of the review process
US$ 24.61
US$ 26.87
US$ 28.34
US$ 20.46
US$ 26.45
US$ 20.80
